Laurus Labs Share Price

ABOUT Laurus Labs

• Industry Biotechnology & Drugs
• ISIN INE947Q01028
• BSE Code 540222
• NSE Code LAURUSLABS

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers an integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. It operates through four divisions: Generics API, Generics FDF, CDMO custom synthesis (Laurus Synthesis), and Biotechnology (Laurus Bio). The Generics API is a third-party API supplier for antiretrovirals. The Generic FDF business focuses on oral solid formulations. Laurus Synthesis provides drug development and manufacturing services to global pharma, crop science, animal health, and others. Laurus Bio offers comprehensive services from clone and strain engineering to production, supporting clients across the microbial precision fermentation spectrum. Its solutions cater for sectors, such as regenerative medicine, vaccines, cultured meat, and others.

MANAGEMENT

• Satyanarayana Chava Chief Executive Officer, Executive Director
• Venkata Ravi Vantaram Chief Financial Officer, Executive Director
• V. Uma Maheswer Rao President Chemical R and D
• Srinivasa Suryadevara President - Manufacturing and Operations
• Thomas Versosky President - FDF, North America
• Jyothi Basu Abbibeni Executive Vice President - Chemical R and D
• Narasimha Chava Executive Vice President - Human Resources
• Rajaram Iyer Executive Vice President Portfolio Management
• Martyn James Peck Executive Vice President Business Development
• Sita Ramaiah Executive Vice President - Finance